Keyphrases
Treatment Planning
100%
Relative Standard Deviation
100%
Peptide Receptor Radionuclide Therapy
100%
Sampling Schedule
100%
Integrated Activities
55%
Activity Coefficient
55%
Liver
33%
Spleen
33%
Physiologically-based Pharmacokinetic Model
33%
Tumor
22%
Iterative Approach
22%
Whole-body
22%
Kidney
22%
Dosimetry
22%
Neuroendocrine Tumor
22%
Image Acquisition
11%
Clinical Setting
11%
Two-parameter
11%
Organs at Risk
11%
Measurement Time
11%
Acceptable Accuracy
11%
Tumor Patients
11%
Parameter Distribution
11%
Absorbed Dose
11%
Number of Measurements
11%
Biokinetics
11%
Individual Treatment
11%
Time-activity Curve
11%
Individual Dosimetry
11%
Octreoscan
11%
Octreotide
11%
Bayesian Information
11%
Reference Time
11%
Gamma Camera Image
11%
Administered Activity
11%
Medicine and Dentistry
Treatment Planning
100%
Radionuclide Therapy
100%
Peptide Receptor
100%
Dosimetry
75%
Pharmacokinetics
75%
Neuroendocrine Tumor
50%
Neoplasm
25%
Absorbed Dose
25%
Gamma Camera
25%
Kidney Tumour
25%
Octreotide
25%
Pentetic Acid
25%
Indium 111
25%
Pentetreotide
25%
Nursing and Health Professions
Receptor
100%
Treatment Planning
100%
Radioisotope
100%
Dosimetry
75%
Area under the Curve
50%
Neuroendocrine Tumor
50%
Neoplasm
25%
Kidney Tumour
25%
Pentetreotide
25%
Play Therapy
25%
Absorbed Dose
25%
Octreotide
25%
Gamma Camera
25%
Pentetic Acid
25%
Indium 111
25%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Dosimetry
100%
Radioisotope
100%
Pharmacokinetics
100%
Neuroendocrine Tumor
66%
Neoplasm
33%
Pentetic Acid
33%
Indium 111
33%
Kidney Tumour
33%
Octreotide
33%
Pentetreotide
33%